Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma

Table 1

Demographics and management outcome.

		Number of eyes	Complete response (%)		Failure (%)		value
Gender	Female	7	4	57	3	43	0.062
	Male	9	9	100	0	0
Laterality	Unilateral	3	3	100	0	0	1.00
	Bilateral	13	10	77	3	23
Vitreous seeds status	Primary	7	5	71	2	28	0.58
	Recurrent	9	8	89	1	11
IIRC	Group C	4	3	75	1	25	1.00
	Group D	12	10	83	2	17
Associated subretinal seeds	With SRS	9	8	89	1	11	0.55
	Without SRS	7	5	71	2	28
Tumor location	Macular	8	5	62	3	37	0.2
	Extramacular	8	8	100	0	0